Clinical Trials Directory

Trials / Completed

CompletedNCT02549313

Effect of the Position of the Patient's Head

Study of the Effect of the Position of the Patient's Head With Brain Lesions on Cerebral Blood Flow

Status
Completed
Phase
Study type
Observational
Enrollment
16 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The position of the head of the patient influences the cerebral venous return and cerebral perfusion pressure (CPP). In our daily practice, it is almost routine to prescribe a Trendelenburg position 30 ° in all brain-damaged patients. However, this is based only on precarious bibliographic databases. It has been shown to decrease the Intracranial Pressure (ICP) in Trendelenburg position relative to the horizontal, with varying effects on PPC. Effects on sylvian objectified by Doppler velocities and cerebral oxygenation seem unaffected by changes of position of the head of the patient. But the whole of the literature on this subject has significant bias.

Detailed description

Registration of blood flow changes induced when the patient's head will be tilted at 0 ° (that is to say flat), 15 ° and 30 ° (the order of actions will be determined by randomization). The patient will remain 10 minutes in each of these positions and will also have a little extra blood sample of 1 ml (ie 9 samples). These measures will be carried out again the next day and then after five days to see if the results vary depending on the evolution of his condition.

Conditions

Interventions

TypeNameDescription
PROCEDUREposition changes of the headRegistration of blood flow changes induced when the patient's head will be tilted at 0 ° (that is to say flat), 15 ° and 30 ° (the order of actions will be determined by drawing lots). The patient will remain 10 minutes in each of these positions.

Timeline

Start date
2012-01-01
Primary completion
2015-10-01
Completion
2015-10-01
First posted
2015-09-15
Last updated
2015-11-03

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02549313. Inclusion in this directory is not an endorsement.